Pirtobrutinib in post-cBTKi CLL/SLL: ∼30 months follow-up and subgroup analysis with/without prior BCL2i from the phase 1/2 BRUIN study Meeting Abstract
| Authors: | Woyach, J. A.; Brown, J. R.; Ghia, P.; Roeker, L. E.; Patel, K.; Eyre, T. A.; Munir, T.; Lech-Maranda, E.; Lamanna, N.; Tam, C. S.; Seymour, J. F.; Tessoulin, B.; Shah, N. N.; Ujjani, C. S.; Fakhri, B.; Coombs, C. C.; Flinn, I. W.; Patel, M.; Nasta, S. D.; Cohen, J. B.; Alencar, A. J.; Cheah, C. Y.; Ma, S.; Rhodes, J. M.; Jagadeesh, D.; Zinzani, P. L.; Osterborg, A.; Izutsu, K.; Tsai, D. E.; Abada, P.; Balbas, M.; Li, J.; Ruppert, A. S.; Jurczak, W.; Wierda, W. G. |
| Abstract Title: | Pirtobrutinib in post-cBTKi CLL/SLL: ∼30 months follow-up and subgroup analysis with/without prior BCL2i from the phase 1/2 BRUIN study |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 325 |
| Language: | English |
| ACCESSION: | WOS:001159306701082 |
| DOI: | 10.1182/blood-2023-185852 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
